Aggressive Recurrent Basal Cell Carcinoma: A Case Report

Basal cell carcinoma (BCC) was first described in 1824 by Jacob who called it “ulcus rodens”: Its current nomenclature wasproposed by Krompecher in 1903. It is the most common type of nonmelanoma skin cancer and the most common malignancyin humans. BCC is typically slow-growing tumor, for which metastases are rare, it can be locally destructive and disfiguring. Thecurrent mainstay of BCC treatment involves surgical modalities such as excision, electrodessication and currettage, cryosurgery,and Mohs’ micrographic surgery. The rates of recurrence are variable in the literature, between 10% and 40 %.